Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia

Completed · Phase 2 · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study aims to evaluate the cognitive enhancing effects and tolerability of GSK239512 compared to placebo in patients with schizophrenia

Key facts

Study ID

NCT01009060

Run by

GlaxoSmithKline

People needed

50

Starts

2009-12-01

Expected to finish

2011-08-10

Last updated by the study team

2017-11-08

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of Schizophrenia
• No acute exacerbation of symptoms requiring hospital admission or step up care in the previous six months.
• Not on any symptomatic treatment for cognition

You may not qualify if…

• Poses a significant homicidal or suicidal risk or evidence of previous homicidal or suicidal risk.
• Co-morbid psychiatric or significant physical illness
• Alcohol or drug abuse or dependence.

Where it is running

• GSK Investigational Site — Garden Grove, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — National City, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Torrance, California, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Catonsville, Maryland, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — Jamaica Plain, Massachusetts, United States
• GSK Investigational Site — Mount Laurel, New Jersey, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Butner, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.